Bladder cancer: Epidemiology, staging and grading, and diagnosis

Parkin, 2002, Volume VIII Ferlay, 2001 Mungan, 2000, Gender differences in stage-adjusted bladder cancer survival, Urology, 55, 876, 10.1016/S0090-4295(00)00523-9 Cantor, 1992, Bladder cancer, parity, and age at first birth, Cancer Causes Control, 3, 57, 10.1007/BF00051913 Green, 1988, Mortality in women in relation to their childbearing history, BMJ, 297, 391, 10.1136/bmj.297.6645.391 Miller, 1980, A study of cancer, parity and age at first pregnancy, J Chronic Dis, 33, 595, 10.1016/0021-9681(80)90002-8 Plesko, 1985, Parity and cancer risk in Slovakia, Int J Cancer, 36, 529, 10.1002/ijc.2910360502 Reid, 1984, Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice, Cancer Res, 44, 4560 2004 Prout, 2004, Survival experience of black patients and white patients with bladder carcinoma, Cancer, 100, 621, 10.1002/cncr.11942 Schairer, 1988, Racial differences in bladder cancer risk a case-control study, Am J Epidemiol, 128, 1027, 10.1093/oxfordjournals.aje.a115047 Foster, 1979, New Zealand Cancer Registry report, Natl Cancer Inst Monogr, 77 Marcus, 2000, Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk, Cancer Epidemiol Biomarkers Prev, 9, 461 Vineis, 1991, Proportion of lung and bladder cancers in males resulting from occupation a systematic approach, Arch Environ Health, 46, 6, 10.1080/00039896.1991.9937423 Markowitz, 2004, Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory, J Occup Environ Med, 46, 154, 10.1097/01.jom.0000111602.76443.15 Popp, 1992, Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform, Br J Ind Med, 49, 529 Schulte, 1987, Occupational cancer of the urinary tract, Occup Med, 2, 85 Steenland, 1999, Cohort mortality study of 57,000 painters and other union members, Occup Environ Med, 56, 315, 10.1136/oem.56.5.315 Marrett, 1986, Bladder cancer and occupational exposure to leather, Br J Ind Med, 43, 96 Gaertner, 2002, Risk of bladder cancer in foundry workers, Occup Environ Med, 59, 655, 10.1136/oem.59.10.655 Romundstad, 2000, Lung and bladder cancer among workers in a Norwegian aluminium reduction plant, Occup Environ Med, 57, 495, 10.1136/oem.57.7.495 Theriault, 1984, Bladder cancer in the aluminium industry, Lancet, 1, 947, 10.1016/S0140-6736(84)92399-7 Boffetta, 2001, A meta-analysis of bladder cancer and diesel exhaust exposure, Epidemiology, 12, 125, 10.1097/00001648-200101000-00021 Kogevinas, 2003, Occupation and bladder cancer among men in Western Europe, Cancer Causes Control, 14, 907, 10.1023/B:CACO.0000007962.19066.9c Zheng, 2002, Occupation and bladder cancer a population-based, case-control study in Iowa, J Occup Environ Med, 44, 685, 10.1097/00043764-200207000-00016 Kantor, 1984, Urinary tract infection and risk of bladder cancer, Am J Epidemiol, 119, 510, 10.1093/oxfordjournals.aje.a113768 Travis, 1995, Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin’s lymphoma, J Natl Cancer Inst, 87, 524, 10.1093/jnci/87.7.524 Kaldor, 1995, Bladder tumours following chemotherapy and radiotherapy for ovarian cancer, Int J Cancer, 63, 1, 10.1002/ijc.2910630102 Bedwani, 1998, Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt, Br J Cancer, 77, 1186, 10.1038/bjc.1998.197 Gelfand, 1967, Relation between carcinoma of the bladder and infestation with Schistosoma haematobium, Lancet, 1, 1249, 10.1016/S0140-6736(67)92714-6 Lucas, 1982, Squamous cell carcinoma of the bladder and schistosomiasis, East Afr Med J, 59, 345 Mustacchi, 1958, Cancer of the bladder and infestation with Schistosoma haematobium, J Natl Cancer Inst, 20, 825 Hartge, 1983, Coffee drinking and risk of bladder cancer, J Natl Cancer Inst, 70, 1021 Jensen, 1986, The Copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages, Int J Cancer, 37, 651, 10.1002/ijc.2910370503 Sala, 2000, Coffee consumption and bladder cancer in nonsmokers, Cancer Causes Control, 11, 925, 10.1023/A:1026524014954 Vineis, 1993, Hypothesis, J Natl Cancer Inst, 85, 1004, 10.1093/jnci/85.12.1004 Sturgeon, 1994, Associations between bladder cancer risk factors and tumor stage and grade at diagnosis, Epidemiology, 5, 218, 10.1097/00001648-199403000-00012 Gago-Dominguez, 2001, Use of permanent hair dyes and bladder-cancer risk, Int J Cancer, 91, 575, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1092>3.0.CO;2-S Henley, 2001, Use of permanent hair dyes and bladder-cancer risk, Int J Cancer, 94, 903, 10.1002/ijc.1547 Kiemeney, 1996, Familial transitional cell carcinoma, J Urol, 156, 867, 10.1016/S0022-5347(01)65644-1 Goldgar, 1994, Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands, J Natl Cancer Inst, 86, 1600, 10.1093/jnci/86.21.1600 Kramer, 1991, Familial aggregation of bladder cancer stratified by smoking status, Epidemiology, 2, 145, 10.1097/00001648-199103000-00010 Aben, 2002, Familial aggregation of urothelial cell carcinoma, Int J Cancer, 98, 274, 10.1002/ijc.10191 Czene, 2002, Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database, Int J Cancer, 99, 260, 10.1002/ijc.10332 Fletcher, 2004, Lifetime risks of common cancers among retinoblastoma survivors, J Natl Cancer Inst, 96, 357, 10.1093/jnci/djh058 Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001 Abrams, 2004 Abrams, 2005, Evidence-based medicine, Volume 1, 10 Taylor, 1996, Papillary urothelial hyperplasia, Am J Surg Pathol, 20, 1481, 10.1097/00000478-199612000-00007 Swierczinski, 2002, Prognostic significance of atypical papillary urothelial hyperplasia, Hum Pathol, 33, 512, 10.1053/hupa.2002.124031 Althausen, 1976, Noninvasive papillary carcinoma of the bladder associated with carcinoma in-situ, J Urol, 116, 575, 10.1016/S0022-5347(17)58916-8 Farrow, 1976, Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy, Cancer Res, 36, 2495 Koss, 1979, Mapping of the urinary bladder, Hum Pathol, 10, 533, 10.1016/S0046-8177(79)80097-0 Smith, 1983, Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer, Br J Urol, 55, 665, 10.1111/j.1464-410X.1983.tb03400.x Hofstäder, 1986, Urothelial dysplasia and carcinoma in situ of the bladder, Cancer, 57, 356, 10.1002/1097-0142(19860115)57:2<356::AID-CNCR2820570228>3.0.CO;2-7 Heney, 1983, Superficial bladder cancer progression and recurrence, J Urol, 130, 1083, 10.1016/S0022-5347(17)51695-X Eble, 1989, Benign and low-grade papillary lesions of the urinary bladder, Semin Diagn Pathol, 6, 351 McKenney, 2002, Urothelial (transitional cell) papilloma of the urinary bladder, Mod Pathol, 15, 174A Desai, 2000, Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia, Mod Pathol, 13, 1315, 10.1038/modpathol.3880241 Holmang, 2001, Stage progression in Ta papillary urothelial tumors, J Urol, 165, 1124, 10.1016/S0022-5347(05)66443-9 Pich, 2001, Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low grade (grade 1) papillary carcinomas of the bladder, Am J Surg Pathol, 25, 1528, 10.1097/00000478-200112000-00009 Cina, 2001, Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia, Arch Pathol Lab Med, 125, 646, 10.5858/2001-125-0646-COKAPW Samaratunga, 2002, Comparison of WHO/ISUP and WHO classification of non-invasive papillary urothelial neoplasms for risk of progression, Urology, 60, 315, 10.1016/S0090-4295(02)01705-3 2004 Lopez-Beltran, 2003, Stage pT1 bladder carcinoma, Pathology, 35, 484, 10.1080/00313020310001619127 1993, Lamina propria microinvasion of bladder tumors, incidence on stage allocation (pTa vs pT1), World J Urol, 11, 161 Tosoni, 2000, Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer, BJU Int, 85, 48, 10.1046/j.1464-410x.2000.00356.x Bol, 2003, Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder, J Urol, 169, 1291, 10.1097/01.ju.0000055471.78783.ae Pagano, 1987, Prognosis of bladder cancer. I. Risk factors in superficial transitional cell carcinoma, Eur Urol, 13, 145, 10.1159/000472760 Younes, 1990, The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder, Cancer, 66, 543, 10.1002/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R Hasui, 1994, Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer, Urology, 43, 782, 10.1016/0090-4295(94)90134-1 Angulo, 1995, Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer, Urology, 45, 47, 10.1016/S0090-4295(95)96490-8 Platz, 1996, Is microstaging of early invasive cancer of the urinary bladder possible or useful?, Mod Pathol, 11, 1035 Holmang, 1997, The importance of the depth of invasion in stage T1 bladder carcinoma, J Urol, 157, 800, 10.1016/S0022-5347(01)65044-4 Hermann, 1998, The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer, J Urol, 159, 91, 10.1016/S0022-5347(01)64021-7 Cheng, 1999, Substaging of T1 bladder carcinoma based on the depth of invasion measured by micrometer, Cancer, 86, 1035, 10.1002/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO;2-D Cheng, 2000, Predicting extravesical extension of bladder carcinoma, Urology, 55, 668, 10.1016/S0090-4295(99)00595-6 Cheng, 1999, Predicting cancer progression in patients with stage T1 bladder carcinoma, J Clin Oncol, 17, 3182, 10.1200/JCO.1999.17.10.3182 Cheng, 1999, Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma, Cancer, 85, 2638, 10.1002/(SICI)1097-0142(19990615)85:12<2638::AID-CNCR21>3.0.CO;2-V Roehrborn, 1991, Long-term patient survival after cystectomy for regional metastastic transitional cell carcinoma of the bladder, J Urol, 146, 36, 10.1016/S0022-5347(17)37708-X Pollack, 1995, The relationship of local control to distant metastasis in muscle invasive bladder cancer, J Urol, 154, 2059, 10.1016/S0022-5347(01)66693-X Quek, 2004, Microscopic and gross extravesical extension in pathological staging of bladder cancer, J Urol, 171, 640, 10.1097/01.ju.0000108664.39035.51 Esrig, 1996, Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion, J Urol, 156, 1071, 10.1016/S0022-5347(01)65705-7 Pagano, 1996, Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement, J Urol, 155, 244, 10.1016/S0022-5347(01)66605-9 Wilson, 1968, Principles and practice of screening for disease, Public Health Pap, 34, 1 Schulte, 1990, Screening for bladder cancer in high-risk groups, J Occup Med, 32, 789, 10.1097/00043764-199009000-00007 Lawrence, 1995, Cost-effectiveness of screening for bladder cancer using chemical reagent strips to detect microscopic hematuria, J Urol, 153, 477a Ellwein, 1990, Bladder cancer screening, J Occup Med, 32, 806, 10.1097/00043764-199009000-00010 Mason, 1990, Bladder cancer screening at the DuPont Chambers Works, J Occup Med, 32, 874, 10.1097/00043764-199009000-00023 Felknor, 2003, Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamine, J Occup Environ Med, 45, 289, 10.1097/01.jom.0000052951.59271.73 Marsh, 1990, A protocol for bladder cancer screening and medical surveillance among high-risk groups, J Occup Med, 32, 881, 10.1097/00043764-199009000-00025 Ward, 1990, Screening workers exposed to 4,4′-methylenebis(2-chloroaniline) for bladder cancer by cystoscopy, J Occup Med, 32, 865, 10.1097/00043764-199009000-00020 Theriault, 1990, Bladder cancer screening among primary aluminum production workers in Quebec, J Occup Med, 32, 869, 10.1097/00043764-199009000-00021 Goessl, 1997, Is routine excretory urography necessary at first diagnosis of bladder cancer?, J Urol, 157, 480, 10.1016/S0022-5347(01)65180-2 Hiatt, 1994, Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urologic cancers in a population-based sample, Cancer Epidemiol Biomarkers Prev, 3, 439 Britton, 1989, Dipstick hematuria and bladder cancer in men over 60, BMJ, 299, 1010, 10.1136/bmj.299.6706.1010 Messing, 1995, Hematuria home screening, J Urol, 154, 57, 10.1016/S0022-5347(01)67224-0 Britton, 1992, A community study of bladder cancer screening by the detection of occult urinary bleeding, J Urol, 148, 788, 10.1016/S0022-5347(17)36720-4 Whelan, 1993, Three-year follow-up of bladder tumors found on screening, Br J Urol, 72, 893, 10.1111/j.1464-410X.1993.tb16292.x Mayfield, 1998, Bladder tumors detected on screening, Br J Urol, 82, 825, 10.1046/j.1464-410X.1998.00879.x Messing, 1995, Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations, Urology, 45, 387, 10.1016/S0090-4295(99)80006-5 Messing, 1990, Hematuria screening for bladder cancer, J Occup Med, 32, 838, 10.1097/00043764-199009000-00016 Kretschmer, 1925, Hematuria, Surg Gynecol Obstet, 40, 683 Varkarakis, 1974, Superficial bladder tumor, Urology, 4, 414, 10.1016/0090-4295(74)90010-7 Lee, 1953, Gross urinary hemorrhage, JAMA, 153, 782, 10.1001/jama.1953.02940260006002 Mohr, 1986, Asymptomatic microhematuria and urologic disease, JAMA, 256, 224, 10.1001/jama.256.2.224 Golin, 1980, Asymptomatic microscopic hematuria, J Urol, 124, 389, 10.1016/S0022-5347(17)55461-0 Sultana, 1996, Microscopic haematuria, Br J Urol, 78, 691, 10.1046/j.1464-410X.1996.01975.x Cummings, 1992, Diagnosis and staging of bladder cancer, Urol Clin North Am, 19, 455, 10.1016/S0094-0143(21)00413-4 1981 Jewett, 1973, Cancer of the bladder, Cancer, 32, 1072, 10.1002/1097-0142(197311)32:5<1072::AID-CNCR2820320508>3.0.CO;2-N Utz, 1984, Carcinoma in situ of the urinary tract, Urol Clin North Am, 11, 735, 10.1016/S0094-0143(21)00780-1 Farrow, 1977, Clinical observations on sixty-nine cases of in-situ carcinoma of the urinary bladder, Cancer Res, 37, 2794 Murphy, 2000 Soloway, 1990, Initial evaluation and response criteria for patients with superficial bladder cancer, Br J Urol, 66, 380, 10.1111/j.1464-410X.1990.tb14958.x Schwalb, 1993, The management of clinically unconfirmed positive urinary cytology, J Urol, 150, 1751, 10.1016/S0022-5347(17)35886-X Malik, 1999, Monitoring patients for bladder neoplasms, Urology, 54, 62, 10.1016/S0090-4295(99)00065-5 Murphy, 1981, The diagnostic value of urine versus bladder washing in patients with bladder cancer, J Urol, 126, 320, 10.1016/S0022-5347(17)54505-X Farrow, 1982, Observations on microinvasive transitional cell carcinoma of the urinary bladder, Clin Oncol, 1, 609 Crosby, 1991, Cytologic detection of urothelial cancer and other abnormalities in a cohort of workers exposed to aromatic amines, Acta Cytol, 35, 263 Koss, 1985, Diagnostic value of cytology of voided urine, Acta Cytol, 29, 810 Rife, 1979, Urine cytology of transitional cell neoplasms, Urol Clin North Am, 6, 599, 10.1016/S0094-0143(21)01216-7 Wiener, 1993, Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer, Acta Cytol, 37, 163 Péz, 1999, Reliability of the routine cytological diagnosis in bladder cancer, Eur Urol, 35, 228, 10.1159/000019851 Murphy, 1984, Urinary cytology and bladder cancer, Cancer, 53, 1555, 10.1002/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G Dean, 1985, Importance of urinary cytology and future role of flow cytometry, Urology, 26, 11 Baltaci, 1996, The efficacy of urinary cytology in the detection of recurrent bladder tumors, Int Urol Nephol, 28, 649, 10.1007/BF02552160 Sack, 1995, Diagnostic value of bladder wash cytology, with special reference to low grade urothelial neoplasms, Acta Cytol, 39, 187 Zein, 1984, Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa, J Urol, 132, 670, 10.1016/S0022-5347(17)49814-4 Raab, 1996, Low-grade transitional cell carcinoma of the urinary bladder, Mod Pathol, 9, 225 Bastacky, 1999, The accuracy of urinary cytology in daily practice, Cancer, 87, 118, 10.1002/(SICI)1097-0142(19990625)87:3<118::AID-CNCR4>3.0.CO;2-N Katz, 1997, Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy, Cancer, 81, 354, 10.1002/(SICI)1097-0142(19971225)81:6<354::AID-CNCR10>3.0.CO;2-Y Herranz-Amo, 1999, Need for intravenous urography in patients with primary transitional carcinoma of the bladder?, Eur Urol, 36, 221, 10.1159/000068001 Yousem, 1988, Synchronous and metachronous transitional cell carcinoma of the urinary tract, Radiology, 167, 613, 10.1148/radiology.167.3.3363119 Hatch, 1986, The value of excretory urography in staging of bladder cancer, J Urol, 135, 49, 10.1016/S0022-5347(17)45511-X Lantz, 1984, Diagnostic imaging of urothelial cancer, Urol Clin North Am, 11, 567, 10.1016/S0094-0143(21)00764-3 Barentsz, 1997, What is new in bladder cancer imaging, Urol Clin North Am, 24, 583, 10.1016/S0094-0143(05)70403-1 Voges, 1989, Computerized tomography, J Urol, 142, 972, 10.1016/S0022-5347(17)38956-5 Paik, 2000, Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy, J Urol, 163, 1693, 10.1016/S0022-5347(05)67522-2 Nurmi, 1988, Reliability of CT in preoperative evaluation of bladder carcinoma, Scand J Urol Nephrol, 22, 125, 10.1080/00365599.1988.11690397 Barentsz, 1996, Staging urinary bladder cancer after transurethral biopsy, Radiology, 201, 185, 10.1148/radiology.201.1.8816542 Herr, 1996, Routine CT scan in cystectomy patients, J Urol, 47, 324, 10.1016/S0090-4295(99)80446-4 Lerner, 2000, Radical cystectomy for bladder cancer, 424 Lindner, 1982, Cost-effective analysis of pre-cystectomy radioisotope scans, J Urol, 128, 1181, 10.1016/S0022-5347(17)53412-6 Berger, 1981, Lack of value of routine preoperative bone and liver scans in cystectomy candidates, J Urol, 125, 637, 10.1016/S0022-5347(17)55144-7 Brismar, 1988, Bone scintigraphy in staging of bladder carcinoma, Acta Radiol, 29, 251, 10.3109/02841858809175003 Utz, 1973, A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder, Cancer, 32, 1075, 10.1002/1097-0142(197311)32:5<1075::AID-CNCR2820320509>3.0.CO;2-B Mulders, 1994, Prognostic factors in pT1-pT1 superficial bladder tumors treated with intra vesical instillations, Br J Urol, 73, 403, 10.1111/j.1464-410X.1994.tb07604.x Jakse, 1987, Stage T1 grade 3 transitional cell carcinoma of the bladder, J Urol, 137, 39, 10.1016/S0022-5347(17)43864-X Abel, 1988, Should pT1 transitional cell cancers of the bladder still be classified as superficial?, Br J Urol, 62, 235, 10.1111/j.1464-410X.1988.tb04325.x Lutzeyer, 1981, Prognostic parameters in superficial bladder cancer, J Urol, 127, 250, 10.1016/S0022-5347(17)53725-8 Dalesio, 1983, Prognostic factors in superficial bladder tumors, J Urol, 129, 730, 10.1016/S0022-5347(17)52330-7 Witjes, 1998, European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group, Urology, 52, 403, 10.1016/S0090-4295(98)00212-X Grimm, 2003, Effect of routine repeat transurethral resection for superficial bladder cancer, J Urol, 170, 433, 10.1097/01.ju.0000070437.14275.e0 Klan, 1991, Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder, J Urol, 146, 316, 10.1016/S0022-5347(17)37779-0 Fitzpatrick, 1986, Superficial bladder tumors (stage pTa grades 1 and 2), J Urol, 135, 920, 10.1016/S0022-5347(17)45923-4 Whitmore, 1965, Ultraviolet cystoscopy in patients with bladder cancer, Trans Am Assoc Genitourin Surg, 57, 149 Vicente, 1987, Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder, Eur Urol, 13, 15, 10.1159/000472728 Kriegmair, 1994, Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid, Urology, 44, 836, 10.1016/S0090-4295(94)80167-3 Kriegmair, 1999, Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy, Eur Urol, 36, 386, 10.1159/000020019 Kriegmair, 1996, Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence, J Urol, 155, 105, 10.1016/S0022-5347(01)66559-5 Jichlinski, 1997, Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid, Lasers Surg Med, 20, 402, 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U König, 1999, Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced 5-aminolevulinic acid, BJU Int, 83, 129, 10.1046/j.1464-410x.1999.00917.x Filbeck, 1999, Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid, J Endourol, 13, 117, 10.1089/end.1999.13.117 Riedl, 1999, Fluorescence detection of bladder tumors with 5-aminolevulinic acid, J Endourol, 13, 755, 10.1089/end.1999.13.755 De Dominicis, 2001, Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer, Urology, 57, 1059, 10.1016/S0090-4295(01)00948-7 Filbeck, 1999, 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors, Urology, 53, 77, 10.1016/S0090-4295(98)00430-0 Zaak, 2001, Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection, J Urol, 166, 1665, 10.1016/S0022-5347(05)65649-2 Zaak, 2002, Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions, Cancer, 95, 1234, 10.1002/cncr.10821 Zaak, 2001, Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid, Urology, 57, 690, 10.1016/S0090-4295(00)01053-0 Schmidbauer, 2004, Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy, J Urol, 171, 135, 10.1097/01.ju.0000100480.70769.0e Filbeck, 2002, Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma?, Urology, 60, 1025, 10.1016/S0090-4295(02)01961-1 Kriegmair, 2002, Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy, J Urol, 168, 475, 10.1016/S0022-5347(05)64661-7 Riedl, 2001, Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer, J Urol, 165, 1121, 10.1016/S0022-5347(05)66442-7 Filbeck, 2002, Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors, J Urol, 168, 67, 10.1016/S0022-5347(05)64833-1 Filbeck, 2003, [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis, Urologe A, 42, 1366, 10.1007/s00120-003-0355-y Milner, 1949, Transurethral biopsy, J Urol, 61, 917, 10.1016/S0022-5347(17)69163-8 Kolozsky, 1991, Histopathological “self control” in transurethral resection of bladder tumors, Br J Urol, 67, 162, 10.1111/j.1464-410X.1991.tb15100.x Soloway, 1992, Surgical techniques for endoscopic resection of bladder cancer, Urol Clin North Am, 19, 467, 10.1016/S0094-0143(21)00414-6 Saito, 2001, Transurethral en bloc resection of bladder tumors, J Urol, 166, 2148, 10.1016/S0022-5347(05)65523-1 Lodde, 2003, En bloc transurethral resection of bladder tumors, Urology, 62, 1089, 10.1016/S0090-4295(03)00761-1 Ukai, 2000, A new technique for transurethral resection of superficial bladder tumor in 1 piece, J Urol, 163, 878, 10.1016/S0022-5347(05)67824-X Solsona, 1992, Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder, J Urol, 147, 1513, 10.1016/S0022-5347(17)37612-7 Reynolds, 1949, Bladder tumors, J Urol, 61, 912, 10.1016/S0022-5347(17)69162-6 Davis, 1952, Ureteral injury by transurethral electroresection and coagulation, J Urol, 68, 168, 10.1016/S0022-5347(17)68183-7 Posta, 1980, Transurethral resection of the carcinomatous ureteral orifice, Int Urol Nephrol, 12, 23, 10.1007/BF02085378 Kisbenedek, 1982, Vesicoureteral reflux following transurethral resection of bladder tumors at the ureteral orifice, Eur Urol, 8, 9, 10.1159/000473468 Gottfries, 1975, Late effects of transurethral resection of bladder tumors at the ureteric orifice, Scand J Urol Nephrol, 9, 32, 10.3109/00365597509139910 Shelfo, 1997, Transurethral resection of bladder cancer, Atlas Urol Clin North Am, 5, 1, 10.1016/S1063-5777(05)70062-1 Amar, 1965, Ureterovesical junction obstruction following transurethral resection, Br J Urol, 37, 307, 10.1111/j.1464-410X.1965.tb09604.x Rees, 1969, The effect of transurethral resection of the intravesical ureter during removal of bladder tumors, Br J Urol, 41, 2, 10.1111/j.1464-410X.1969.tb09900.x Freed, 1976, Vesicoureteral reflux following transurethral resection of bladder tumors, J Urol, 116, 184, 10.1016/S0022-5347(17)58740-6 Palou, 1991, Upper tract urothelial tumor after transurethral resection for bladder tumor, Eur Urol, 21, 110, 10.1159/000474814 De Torres Mateos, 1987, Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma, J Urol, 138, 49, 10.1016/S0022-5347(17)42984-3 Amar, 1985, Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux, J Urol, 133, 468, 10.1016/S0022-5347(17)49028-8 Amar, 1983, Vesicoureteric reflux in patients with bladder tumors, Br J Urol, 55, 483, 10.1111/j.1464-410X.1983.tb03353.x Gonzalez Martin, 1991, Endoscopic treatment of vesicoureteral reflux following transurethral resection of a vesical carcinoma by Teflon injection, Eur Urol, 19, 291, 10.1159/000473645 Hobika, 1961, Use of neuromuscular blocking drugs to counteract thigh-adductor spasm induced by electrical shocks of obturator nerve during transurethral resection of bladder tumors, J Urol, 85, 295, 10.1016/S0022-5347(17)65326-6 Prentiss, 1965, Massive adductor muscle contraction in transurethral surgery, J Urol, 93, 263, 10.1016/S0022-5347(17)63757-1 Augspurger, 1980, Prevention of obturator nerve stimulation during transurethral surgery, J Urol, 123, 170, 10.1016/S0022-5347(17)55837-1 Redman, 1976, Management of neoplasms in vesical diverticula, Urology, 7, 492, 10.1016/0090-4295(76)90186-2 Golijanin, 2003, Carcinoma in a bladder diverticulum, J Urol, 170, 1761, 10.1097/01.ju.0000091800.15071.52 Melekos, 1987, Vesical diverticula etiology, diagnosis, tumorigenesis, and treatment, Urology, 30, 453, 10.1016/0090-4295(87)90378-5 Dick, 1980, Complications of transurethral resection of bladder tumors, J Urol, 124, 810, 10.1016/S0022-5347(17)55677-3